Covered recipient · General Payments record
RODNEY SMITH
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2024
$3,034.40
- Reported across 241 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $449.66 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $267.94 | 26 |
| Astellas Pharma US Inc | $95.66 | 6 |
| GlaxoSmithKline, LLC. | $71.40 | 3 |
| Otsuka America Pharmaceutical, Inc. | $14.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $0.87 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126918 | CMS |
| ABBVIE INC. | $14.89 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126920 | CMS |
| ABBVIE INC. | $6.21 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126922 | CMS |
| ABBVIE INC. | $16.34 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126924 | CMS |
| ABBVIE INC. | $15.37 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126926 | CMS |
| ABBVIE INC. | $10.37 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126928 | CMS |
| ABBVIE INC. | $4.99 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126930 | CMS |
| ABBVIE INC. | $26.67 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126932 | CMS |
| ABBVIE INC. | $5.89 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126934 | CMS |
| ABBVIE INC. | $21.98 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126936 | CMS |
| ABBVIE INC. | $4.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126938 | CMS |
| ABBVIE INC. | $9.52 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126940 | CMS |
| ABBVIE INC. | $6.19 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126942 | CMS |
| ABBVIE INC. | $10.73 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126944 | CMS |
| ABBVIE INC. | $9.61 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126946 | CMS |
| ABBVIE INC. | $4.25 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126948 | CMS |
| ABBVIE INC. | $10.73 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126950 | CMS |
| ABBVIE INC. | $10.43 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126952 | CMS |
| ABBVIE INC. | $9.73 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126954 | CMS |
| ABBVIE INC. | $17.37 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126956 | CMS |
| ABBVIE INC. | $6.77 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126958 | CMS |
| ABBVIE INC. | $11.31 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126960 | CMS |
| ABBVIE INC. | $8.91 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126962 | CMS |
| ABBVIE INC. | $5.30 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126964 | CMS |
| ABBVIE INC. | $13.91 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126966 | CMS |
| ABBVIE INC. | $5.27 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106126968 | CMS |
| Astellas Pharma US Inc | $15.91 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139262702 | CMS |
| Astellas Pharma US Inc | $15.91 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139285898 | CMS |
| Astellas Pharma US Inc | $16.54 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299604 | CMS |
| Astellas Pharma US Inc | $15.91 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139325198 | CMS |
| Astellas Pharma US Inc | $17.17 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139281828 | CMS |
| Astellas Pharma US Inc | $14.22 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139389084 | CMS |
| GlaxoSmithKline, LLC. | $23.59 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116735696 | CMS |
| GlaxoSmithKline, LLC. | $25.31 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116659767 | CMS |
| GlaxoSmithKline, LLC. | $22.50 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116449689 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.66 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118985690 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.